Reuters
2 minute read
Signage is seen at the headquarters of the United States Department of Justice (DOJ) in Washington, D.C., U.S., May 10, 2021. REUTERS/Andrew Kelly
The U.S. Justice Department said on Tuesday that it had seized two Internet domains that had been used in spear-phishing attacks that mimicked email communications from the U.S. Agency for International Development.
The Justice Department said that it seized two command-and-control (C2) and malware distribution domains on May 28 after winning a court order to do so. The seizure was done in hopes of identifying groups that had been victimized and stopping future victimization.
Jonathan Stempel
1/2
Rudolph Giuliani, former Mayor of New York City, delivers a speech during the 2018 Iran Uprising Summit in Manhattan, New York, U.S., September 22, 2018. REUTERS/Amr Alfiky
Read More
A U.S. federal judge on Friday ordered an independent review of evidence from electronic devices seized in recent raids of Rudy Giuliani s home and office, rejecting Giuliani s effort to block the review.
U.S. District Judge Paul Oetken in Manhattan said appointing a special master would ensure the perception of fairness in reviewing the 18 devices, including cellphones and computers, taken during the April 28 raids.
Federal prosecutors in Manhattan have been examining Giuliani s dealings in Ukraine, including whether he violated lobbying laws by acting as an unregistered foreign agent while working as a lawyer for then-U.S. President Donald Trump.
Marisa TaylorMike SpectorDan Levine
1/2
Eli Lilly logo is shown on one of the company s offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo
Read More
The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co (LLY.N) focused on alleged manufacturing irregularities and records tampering at a factory in Branchburg, New Jersey, that produces the pharmaceutical giantâs COVID-19 therapy and other drugs, three people familiar with the matter said.
The probe represents a significant escalation of the government scrutiny on Lilly. The pharmaceutical company, one of the world s largest, has been under examination for more than a year by the U.S. Food and Drug Administration over alleged manufacturing and records violations at the Branchburg factory.